News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AlloCure Inc. Appoints Kevin J. Heyeck as Chief Business Officer



2/14/2011 8:47:40 AM

BURLINGTON, Mass.--(BUSINESS WIRE)--AlloCure Inc., a biotechnology company developing innovative therapies for the treatment of kidney disease, today announced the appointment of Kevin J. Heyeck as Chief Business Officer. Mr. Heyeck, who brings more than twenty years of experience in business development leadership and corporate partnering for emerging pharmaceutical companies, previously led business development efforts at Vitae Pharmaceuticals, and before that, Pharmacopeia.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES